This brand name is authorized in Estonia, Spain, Ireland, Japan, Lithuania, New Zealand
The drug UROGRAFIN contains one active pharmaceutical ingredient (API):
|
1
Diatrizoic acid
UNII 5UVC90J1LK - DIATRIZOIC ACID
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| UROGRAFIN Solution for infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V08AA01 | Diatrizoic acid | V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1079412 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 23817 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 7214400A2034, 7214400A5041, 7214400A6030 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1010502, 1010503, 1031777, 1091061 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 711, 712 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
